Reply to the letter to the editor

DOI: 10.4244/EIJ-D-23-00857

Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

Gerald S. Werner1, MD, PhD; David Hildick-Smith2, MD; for the EuroCTO trial investigators.

The author of the letter expresses concerns about percutaneous coronary intervention (PCI) for chronic total coronary occlusions (CTO)1. The author cites a “very high” complication rate in studies that compared successful and unsuccessful CTO PCI procedures. Failed procedures are associated with higher complication rates than successful procedures, certainly, and indeed the randomised EuroCTO study confirms this observation. We found a significant increase in complication rates after failed procedures, but successful procedures resulted in outcomes that were better than with medical management2.

The author comments that in US community hospitals, complication rates for CTO PCI are higher than for non-CTO lesions3. This is not surprising. CTO PCI is a highly complex procedure and, when undertaken by non-specialist operators, has a lower procedural success rate and a higher complication rate. There is a clear relationship between volume and outcome4. CTO PCI is not a routine procedure to be performed by any operator in every institution. It requires training, experience, and familiarity with dedicated equipment and techniques. Indeed the EuroCTO club has emphasised the need for dedicated CTO PCI...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 1
Jan 1, 2024
Volume 20 Number 1
View full issue


Key metrics

On the same subject

10.4244/EIJV15I2A27 Jun 20, 2019
Chronic total occlusion percutaneous coronary intervention: the road ahead
Brilakis E et al
free

Editorial

10.4244/EIJ-E-23-00040 Sep 18, 2023
Reconsidering the evidence for CTO PCI: the devil is in the detail
Al-Lamee R et al
free

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
Trending articles
339.13

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
312.48

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
295.45

Expert consensus

10.4244/EIJ-D-21-00898 Sep 20, 2022
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Secemsky E et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
149.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved